3 results about "Anserine" patented technology

An imidazole dipeptide composition having renal protective efficacy and its application. The imidazole dipeptide composition having renal protective efficacy comprises anserine and carnosine, wherein, when the total weight of anserine and carnosine is 100%, the content of anserine is 10% to 99% and the content of carnosine is 1% to 90%. In a mouse test, mice with hyperuric kidney damage showed significantly less kidney damage compared to the control group after continuously consuming the imidazole dipeptide composition for a certain period, and the imidazole dipeptide composition was proven to have an excellent renal protective effect.

The present application relates to the technical field of food and beverage processing, and discloses a milk tea based on synergistic buffering of goose dipeptide and dipeptide and a preparation method thereof.The milk tea contains, by weight percentage, 0.15%-0.45% of a core dipeptide compound, 5.0%-10.0% of a plant or A2 milk powder matrix, 0.02%-0.08% of a neuromodulator, 0.05%-0.15% of a metabolic auxiliary factor, and sweeteners, flavor modifiers and pH buffers.The mass ratio of goose dipeptide to dipeptide in the core dipeptide compound is 3:1-4:1, and the dipeptide is double-modified by beta-cyclodextrin embedding and tea polyphenol complexing to mask the astringent taste of the dipeptide.The preparation process adopts tea-milk base high-temperature sterilization, active liquid cross-flow membrane cold filtration sterilization, separate cavity dosing and aseptic cold filling technology to block the Maillard reaction of heat-sensitive peptides.The present application can target intervention in the increase of uric acid, lactic acid accumulation and tissue glycation caused by night work, and relieve physiological metabolic abnormalities.

This invention belongs to the fields of traditional Chinese medicine and biomedicine, specifically relating to compositions that promote lactation, their preparation methods, and applications. First, this invention establishes an animal model of lactation deficiency to evaluate the efficacy of traditional Chinese medicine, natural products, and their combinations in promoting lactation. Using this model, a large number of naturally derived active ingredients were screened, yielding highly effective active ingredients such as astragaloside A, codonopsis glycoside, ferulic acid, lycine spermidine, carnosine, and anserine. These active ingredients were then combined to prepare compositions. Based on this, traditional Chinese medicine compositions and food-medicine homologous traditional Chinese medicine compositions with the aforementioned active ingredients as their core were also prepared. This invention evaluated the three compositions using the lactation deficiency animal model, finding that all three compositions significantly promoted lactation. Therefore, this invention has significant clinical value and broad market application prospects, and can meet the needs of people requiring lactation.